Tag: Skin Disorders: Misc.

All primary and key secondary end points met in two phase 3 trials of adults with PN with ≥20 nodules

Dersimelagon at doses of 100 and 300 mg increases duration of symptom-free sunlight exposure versus placebo

The 2023 American Academy of Dermatology Annual Meeting

60.5 percent of participants in memantine group were much or very much improved compared with 8.3 percent in placebo group

Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50

Deep learning algorithm can accurately identify the area subscore of the Palmoplantar Pustulosis Area and Severity Index

Concerns were few and included not understanding notes or abbreviations

However, more frequent headache, dizziness, constipation, increased urine output seen for patients receiving difelikefalin versus placebo

However, scar located on lower lid mid subunit perpendicular to facial tension lines was rated as less attractive

Thermal images taken in home settings at week 0 can discriminate healed from unhealed leg venous ulcer wounds